详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Discovery of a novel class of pyridine derivatives that selectively inhibits mutant isocitrate dehydrogenase 2.

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School of Sichuan University, Chengdu, China [2]Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, China [3]Hinova Pharmaceuticals Inc., Chengdu, China

出处：

DOI：

ISSN：

关键词： enzyme-based assay IDH IDH2 R140Q mutation pyridine derivatives SAR study

摘要：

This paper presents synthesis and structure-activity relationship of pyridine derivatives as inhibitors of mutant isocitrate dehydrogenase 2 (IDH2). A series of 2,4,6-trisubstituted pyridine derivatives have been prepared and evaluated in vitro. Among these compounds, 14n exhibited excellent inhibition activity with the IC50 of 54.6 nm, which is approximately onefold improvement compared to drug candidate AG-221 (Enasidenib) that is in Phase III trial. Exquisite selectivity of 14n for IDH2 R140Q mutant isoform was demonstrated by the poor activity against the wild-type IDH1 and IDH2. © 2017 John Wiley & Sons A/S.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2018]版：

大类 | 3 区医学

小类 | 3 区药物化学 4 区生化与分子生物学

最新[2023]版：

大类 | 4 区医学

小类 | 4 区生化与分子生物学 4 区药物化学

第一作者：

第一作者机构： [1]State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School of Sichuan University, Chengdu, China

共同第一作者：

通讯作者：

通讯机构： [1]State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School of Sichuan University, Chengdu, China [2]Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, China [3]Hinova Pharmaceuticals Inc., Chengdu, China [*1]Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, China. [*2]State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School of Sichuan University, Chengdu, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Discovery and SAR Study of Quinoxaline-Arylfuran Derivatives as a New Class of Antitumor Agents [2]Synthesis and biological evaluation of 1, 2, 4-oxadiazole derivatives as novel GPR119 agonists. [3]Design, synthesis, and biological evaluation of quinazoline derivatives as dual HDAC1 and HDAC6 inhibitors for the treatment of cancer. [4]SAR Study and Molecular Mechanism Investigation of Novel Naphthoquinone-furan-2-cyanoacryloyl Hybrids with Antitumor Activity [5]Synthesis and biological evaluation of 1, 2, 4-oxadiazole derivatives as novel GPR119 agonists. [6]PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma [7]Development of novel phenoxy-diketopiperazine-type plinabulin derivatives as potent antimicrotubule agents based on the co-crystal structure. [8]Stalled oligodendrocyte differentiation in IDH-mutant gliomas [9]Synthesis, SAR study, and bioactivity evaluation of a series of Quinoline-Indole-Schiff base derivatives: Compound 10E as a new Nur77 exporter and autophagic death inducer. [10]Systemic screening identifies GABRD, a subunit gene of GABAA receptor as a prognostic marker in adult IDH wild-type diffuse low-grade glioma